Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Cancer ; 22(1): 337, 2022 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-35351058

RESUMEN

OBJECTIVE: Failure rate in randomized controlled trials (RCTs) is > 50%, includes safety-problems, underpowered statistics, lack of efficacy, lack of funding or insufficient patient recruitment and is even more pronounced in oncology trials. We present results of a structured concept-development phase (CDP) for a phase III RCT on personalized radiotherapy (RT) in primary prostate cancer (PCa) patients implementing prostate specific membrane antigen targeting positron emission tomography (PSMA-PET). MATERIALS AND METHODS: The 1 yr process of the CDP contained five main working packages: (i) literature search and scoping review, (ii) involvement of individual patients, patients' representatives and patients' self-help groups addressing the patients' willingness to participate in the preparation process and the conduct of RCTs as well as the patient informed consent (PIC), (iii) involvement of national and international experts and expert panels (iv) a phase II pilot study investigating the safety of implementation of PSMA-PET for focal dose escalation RT and (v) in-silico RT planning studies assessing feasibility of envisaged dose regimens and effects of urethral sparing in focal dose escalation. RESULTS: (i) Systematic literature searches confirmed the high clinical relevance for more evidence on advanced RT approaches, in particular stereotactic body RT, in high-risk PCa patients. (ii) Involvement of patients, patient representatives and randomly selected males relevantly changed the PIC and initiated a patient empowerment project for training of bladder preparation. (iii) Discussion with national and international experts led to adaptions of inclusion and exclusion criteria. (iv) Fifty patients were treated in the pilot trial and in- and exclusion criteria as well as enrollment calculations were adapted accordingly. Parallel conduction of the pilot trial revealed pitfalls on practicability and broadened the horizon for translational projects. (v) In-silico planning studies confirmed feasibility of envisaged dose prescription. Despite large prostate- and boost-volumes of up to 66% of the prostate, adherence to stringent anorectal dose constraints was feasible. Urethral sparing increased the therapeutic ratio. CONCLUSION: The dynamic framework of interdisciplinary working programs in CDPs enhances robustness of RCT protocols and may be associated with decreased failure rates. Structured recommendations are warranted to further define the process of such CDPs in radiation oncology trials.


Asunto(s)
Neoplasias de la Próstata , Oncología por Radiación , Estudios de Factibilidad , Humanos , Masculino , Próstata , Neoplasias de la Próstata/radioterapia , Tomografía Computarizada por Rayos X
2.
Strahlenther Onkol ; 192(11): 770-779, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27334276

RESUMEN

PURPOSE: The prognosis for high-grade glioma (HGG) patients is poor; thus, treatment-related side effects need to be minimized to conserve quality of life and functionality. Advanced techniques such as proton radiation therapy (PRT) and volumetric-modulated arc therapy (VMAT) may potentially further reduce the frequency and severity of radiogenic impairment. MATERIALS AND METHODS: We retrospectively assessed 12 HGG patients who had undergone postoperative intensity-modulated proton therapy (IMPT). VMAT and 3D conformal radiotherapy (3D-CRT) plans were generated and optimized for comparison after contouring crucial neuronal structures important for neurogenesis and neurocognitive function. Integral dose (ID), homogeneity index (HI), and inhomogeneity coefficient (IC) were calculated from dose statistics. Toxicity data were evaluated. RESULTS: Target volume coverage was comparable for all three modalities. Compared to 3D-CRT and VMAT, PRT showed statistically significant reductions (p < 0.05) in mean dose to whole brain (-20.2 %, -22.7 %); supratentorial (-14.2 %, -20,8 %) and infratentorial (-91.0 %, -77.0 %) regions; brainstem (-67.6 %, -28.1 %); pituitary gland (-52.9 %, -52.5 %); contralateral hippocampus (-98.9 %, -98.7 %); and contralateral subventricular zone (-62.7 %, -66.7 %, respectively). Fatigue (91.7 %), radiation dermatitis (75.0 %), focal alopecia (100.0 %), nausea (41.7 %), cephalgia (58.3 %), and transient cerebral edema (16.7 %) were the most common acute toxicities. CONCLUSION: Essential dose reduction while maintaining equal target volume coverage was observed using PRT, particularly in contralaterally located critical neuronal structures, areas of neurogenesis, and structures of neurocognitive functions. These findings were supported by preliminary clinical results confirming the safety and feasibility of PRT in HGG.


Asunto(s)
Astrocitoma/radioterapia , Neoplasias Encefálicas/radioterapia , Glioblastoma/radioterapia , Terapia de Protones/métodos , Dosificación Radioterapéutica , Radioterapia de Intensidad Modulada/métodos , Adulto , Lesiones Encefálicas/etiología , Lesiones Encefálicas/prevención & control , Irradiación Craneana/efectos adversos , Irradiación Craneana/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Órganos en Riesgo/efectos de la radiación , Terapia de Protones/efectos adversos , Exposición a la Radiación , Traumatismos por Radiación/etiología , Traumatismos por Radiación/prevención & control , Protección Radiológica/métodos , Planificación de la Radioterapia Asistida por Computador/métodos , Radioterapia de Intensidad Modulada/efectos adversos , Estudios Retrospectivos , Resultado del Tratamiento
3.
Dtsch Med Wochenschr ; 136(24): 1299-304, 2011 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-21656449

RESUMEN

UNLABELLED: BACKGROUND AND OBJEKTIVES: In 1988 the German Vaccination Board (STIKO) at the Robert-Koch-Institute (RKI) in Berlin, recommended that German health care workers should be vaccinated annually against influenza. Despite this, vaccination rates have remained low (20 %). Between January and March 2009 a study was performed at the University Clinical Centre in Essen to determine reasons for low influenza vaccination rates and to assess improvement strategies. METHODS: All employees and staff members of the University Hospital (n = 5349) were asked to fill in a questionnaire anonymously. The completed questionnaires were digitalized and the results analysed electronically. RESULTS: 1 670 of the 5 349 (31 %) questionnaires were found to be satisfactory for evaluation. The vaccination rate among this cohort was 29 %. Vaccination rates varied widely between different departments (4 - 71 %). The most common reason for not undergoing vaccination was "forgotten" (32 %). The second most common reason was the fear of side effects (30 %). Only 32 % of the employees stated that the quality of the information about influenza vaccination provided by their employer was "good" or "very good". CONCLUSION: The vaccination rate of 29 % among this group of health care workers was higher than the average (20 %) in German hospitals and highest among medical doctors. Strikingly enough employees of theoretic departments were vaccinated to a higher percentage than those providing nursing care and thus had more frequent contact to patients. A number of comparatively basic and inexpensive measures would be enough to increase vaccination rates significantly.


Asunto(s)
Personal Administrativo/estadística & datos numéricos , Técnicos Medios en Salud/estadística & datos numéricos , Infección Hospitalaria/prevención & control , Infección Hospitalaria/transmisión , Hospitales Universitarios/estadística & datos numéricos , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , Gripe Humana/transmisión , Vacunación Masiva/estadística & datos numéricos , Cuerpo Médico de Hospitales/estadística & datos numéricos , Personal de Enfermería en Hospital/estadística & datos numéricos , Adulto , Femenino , Alemania , Encuestas Epidemiológicas , Humanos , Transmisión de Enfermedad Infecciosa de Profesional a Paciente/prevención & control , Vacunas contra la Influenza/efectos adversos , Masculino , Persona de Mediana Edad , Motivación , Infecciones Oportunistas/prevención & control , Infecciones Oportunistas/transmisión , Encuestas y Cuestionarios , Revisión de Utilización de Recursos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...